BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cordis Corporation today announced the presentation of the INCRAFT™ AAA Stent-Graft System INNOVATION study one-year results at the 2012 Veith Symposium in New York ...

Aortic aneurysm disease is among the leading cause of death in the U.S., estimated to affect 1.7 million people over the age of 55. The incidence for abdominal aortic aneurysms (AAA), a bulging, ...

New Clinical Data from PANDORA and ENGAGE Affirm Market-Leading Medical Device's Durable, Consistent and Proven Outcomes In Endovascular Treatment of Abdominal Aortic Aneurysms MINNEAPOLIS --The ...

Latest Results from Two Clinical Studies Show Strong Mid-Term Performance of Leading Medical Device for Endovascular Repair of Abdominal Aortic Aneurysms MINNEAPOLIS -- For endovascular repair of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The FDA issued an alert recommending ...

Medtronic (Minneapolis) has received FDA approval to sell its Endurant AAA stent graft system in the U.S. for the minimally invasive treatment of AAA, a largely unknown and often fatal condition.

Please provide your email address to receive an email when new articles are posted on . In patients who received a stent graft for endovascular abdominal aortic aneurysm repair, rates of ...

The US Food and Drug Administration (FDA) has long kept a watchful eye over successive iterations of endovascular stent graphs in the Endologix AFX line, designed for repair of abdominal aortic ...

Endologix’s current commercial EVAR products include the AFX®2 Endovascular AAA System and the ALTO® Abdominal Stent Graft System. On October 1, 2020, Endologix became a private company, wholly owned ...

FDA has approved new labeling for Medtronic’s Endurant stent graft system. The Dublin-based company said the labeling approval adds ruptured abdominal aortic aneurysm (rAAA) clinical evidence and ...

The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic aneurysms from its label. A retrospective study confirms that women can get ...